vTv Therapeutics (VTVT) Non Operating Income (2014 - 2016)

vTv Therapeutics (VTVT) reported Non Operating Income of $21000.0 for Q3 2016, up 425.0% on a YoY basis from $4000.0 in Q4 2015, and little changed sequentially from $21000.0 in Q2 2016.

vTv Therapeutics (VTVT) Non Operating Income (2014 - 2016) Analysis & Trends

vTv Therapeutics (VTVT) has 3 years of Non Operating Income data on file, last reported at $21000.0 in Q3 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -9.22 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 444,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - 5.75 Mn
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -8.59 Mn
10 vTv Therapeutics 19.21 Mn 19.21 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2016 21,000.00
Jun 30, 2016 21,000.00
Mar 31, 2016 21,000.00
Sep 30, 2015 4,000.00
Jun 30, 2015 -45,000.00
Mar 31, 2015 -45,000.00
Sep 30, 2014 -33,000.00